生物技术领域金融工程的奇闻异事
在生物技术领域，金融工程被用来创造复杂融资结构，如研发融资、特许权使用费交易和里程碑付款证券化。这些创新工具帮助生物科技公司分担高风险药物开发成本，但也可能掩盖潜在财务风险，给投资者带来额外不确定性。文章通过具体案例展示了金融工程如何既推动行业创新又制造隐藏陷阱。
相关报道
Job seekers face a tough environment, but widespread AI-caused job losses have been overblown so far. Instead, AI is creating demand for workers with AI skills, while those who don't adapt may face replacement. Companies are building smaller, AI-native teams as AI makes individuals more productive.
YC's official advice urges founders to be precise and honest about distinguishing between pilots, bookings, revenue, and recurring revenue, warning against confusing one category for another.
The article examines how 4,000 companies faced a disruptive technology in the early 20th century, with only one surviving. It explores why leaders often fail to adapt to technological changes that threaten their existing business models.
While employment changes due to AI are expected to become significant over time, immediate widespread disruption is not anticipated. The transition will likely be gradual rather than sudden.
Andrew Ng writes from the World Economic Forum that businesses need to move beyond incremental AI efficiency gains to achieve transformative impact. He argues that workflow redesign, rather than isolated AI projects, is key to creating significant business value, using loan processing as an example where end-to-end changes can transform product offerings.